The evaluation of acute renal failure (ARF) by the newly developed classification for ARF (RIFLE, standing for \'risk, injury, failure, loss, end-stage kidney disease\') \[[@B1]\] in patients with sepsis has not yet been performed. We evaluated, retrospectively, the incidence of ARF and its risk factors, therapy, and outcome among patients with sepsis admitted to the Infectious Diseases Intensive Care Unit of the Hospital de Santa Maria between January 2005 and December 2006. ARF was defined by means of the RIFLE classification \[[@B1]\]. Sepsis was classified in accordance with the American College of Chest Physicians and the Society of Critical Care Medicine consensus \[[@B2]\]. In all, 182 patients (aged 56.2 ± 18.56 years (mean ± SD), 120 male, 162 Caucasian) were analyzed. Baseline characteristics of the patients are summarized in Table [1](#T1){ref-type="table"}. Sixty-eight patients (37.4%) had ARF. By multivariate analysis, age more than 60 years (odds ratio (OR) 0.39, 95% confidence interval (CI) 0.17 to 0.87, *P*= 0.002), male (OR 5.5, 95% CI 2.2 to 13.5, *P*\< 0.0001), chronic kidney disease (OR 0.2, 95% CI 0.06 to 0.79, *P*= 0.021), Gram-negative-related infection (OR 0.38, 95% CI 0.16 to 0.89, *P*= 0.027), and a Simplified Acute Physiology Score, version II (SAPS II) \> 50 (OR 0.14, 95% CI 0.06 to 0.31, *P*\< 0.0001) were independently associated with ARF. Thirteen patients (3 with injury and 10 with renal failure) had received renal replacement therapy (12 receiving continuous venovenous hemodiafiltration, and 1 receiving intermittent hemodialysis). The mortality rate was 37.4%, and increased from \'normal\' to \'failure\'. Patients who did not die had renal function recovery. Multivariate analysis including age more than 60 years, gender, SAPS II \> 50, comorbidity (namely cardiovascular disease), and ARF showed that SAPS II \> 50 (OR 0.12, 95% CI 0.05 to 0.29, *P*\< 0.0001) and ARF (OR 0.26, 95% CI 0.11 to 0.63, *P*= 0.003) were independent predictors of mortality.

###### 

Baseline characteristics

  Variable           No AKI       Risk          Injury        Failure       *P*
  ------------------ ------------ ------------- ------------- ------------- ----------
  *n*                114          11            21            36            
  Age (years)^a^     54 ± 18.2    61.9 ± 20.9   61.6 ± 13.4   61.8 ± 16.3   NS
  Sex (male)         65 (57)      10 (91)       18 (85.7)     27 (75)       0.009
  Race (Caucasian)   102 (89.5)   10 (91)       20 (95.2)     30 (83.3)     NS
  Severe sepsis^b^   77 (67.5)    6 (54.5)      12 (57.1)     13 (36.1)     0.012
  Septic shock^b^    25 (21.9)    4 (36.4)      8 (38)        23 (64)       \<0.0001
  CVD                37 (32.4)    3 (27.3)      10 (47.6)     14 (38.9)     NS
  CKD                5 (43.9)     1 (9)         4 (19)        8 (22.2)      0.009
  SAPS II \> 50      22 (19.3)    6 (54.5)      7 (33.3)      9 (26.5)      0.06
  Mortality          11 (9.6)     3 (27.3)      6 (28.6)      20 (55)       \<0.0001

Figures in parentheses are percentages. AKI, acute kidney injury; CKD, chronic kidney disease; CVD, cardiovascular disease, diabetes mellitus and hypertension; NS, not significant; SAPS II, Simplified Acute Physiology Score, version II. The SAPS II was calculated on the basis of the worst variables recorded during the first 24 hours of ICU admission. ^a^Means ± SD; ^b^sepsis was classified in accordance with American College of Chest Physicians and the Society of Critical Care Medicine consensus \[2\].

Thus, ARF as determined by RIFLE is common among patients with sepsis, and increases mortality. Age, gender, chronic kidney disease, Gram-negative-related infection and severity of illness are independently associated with ARF in this setting.
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